These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5909431)

  • 1. Sustained release tablets for potassium chloride administration. A pharmacological study.
    Bervenmark H; Eriksson G; Ljungberg S; Paalzow L
    Acta Pharm Suec; 1966 Feb; 3(1):45-58. PubMed ID: 5909431
    [No Abstract]   [Full Text] [Related]  

  • 2. Potassium absorption from sustained release tablets.
    Graffner C; Sjögren J
    Acta Pharm Suec; 1971 Mar; 8(1):13-8. PubMed ID: 5575869
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets].
    Lévy VG; Caroli J
    Therapeutique; 1971 Dec; 47(10):845-51. PubMed ID: 5145546
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vivo and in vitro studies of the release of active ingredients in solid oral pharmaceutical preparations containing potassium chloride].
    Ekes G; Szentmiklósi P; Rácz I; Mezei J; Küttel S; Jancsó S
    Acta Pharm Hung; 1985 Sep; 55(5):163-7. PubMed ID: 4061085
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet.
    Tannen RL; Cordano A
    J Pharmacol Exp Ther; 1978 Jan; 204(1):240-6. PubMed ID: 304099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotrix and other slow-release potassium tablets.
    Med Lett Drugs Ther; 1981 Jan; 23(1):3-4. PubMed ID: 7453668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of two commercial potassium chloride tablets for slow-release in an in vitro dissolution test].
    Wu PC; Huang YB; Chang SJ; Ko HM; Tsai YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Mar; 8(3):161-7. PubMed ID: 1560473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and old potassium preparations.
    Drug Ther Bull; 1969 Jan; 7(3):9-10. PubMed ID: 5770285
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro biopharmaceutical control of drugs. 3. Comparative study of delayed-release potassium chloride-containing oral preparations].
    Keserü P; Szalai H; Paál T
    Acta Pharm Hung; 1982 Jul; 52(4):163-70. PubMed ID: 7170979
    [No Abstract]   [Full Text] [Related]  

  • 10. Potassium chloride tablets and small bowel stenoses and perforations: two studies in the French Pharmacovigilance system.
    Tréchot P; Moore N; Bresler L; Castot A; Gay G; Netter P; Royer R
    Am J Gastroenterol; 1994 Aug; 89(8):1268. PubMed ID: 8053453
    [No Abstract]   [Full Text] [Related]  

  • 11. The absorption of potassium chloride--liquid vs. tablet.
    Levene DL
    Can Med Assoc J; 1973 Jun; 108(12):1480 passim. PubMed ID: 4714871
    [No Abstract]   [Full Text] [Related]  

  • 12. Potassium absorption--a comparison of in vitro and in vivo studies.
    Jouhar AJ; Garnett ES; Wallington JS
    J Pharm Sci; 1968 Apr; 57(4):617-20. PubMed ID: 5652153
    [No Abstract]   [Full Text] [Related]  

  • 13. Ulceration and stricture of the esophagus due to oral potassium chloride (slow release tablet) therapy.
    Lambert JR; Newman A
    Am J Gastroenterol; 1980 Jun; 73(6):508-11. PubMed ID: 7424872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology update: slow-release potassium chloride supplements.
    Romankiewicz N
    J Pract Nurs; 1983; 33(7):7-8. PubMed ID: 6555240
    [No Abstract]   [Full Text] [Related]  

  • 15. A contribution to the preparation of matrix-type sustained release tablets.
    Ellö I; Grünwald-Fischer A; Hortobágyi V
    Dan Tidsskr Farm; 1968; 42(7):185-95. PubMed ID: 5724489
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO; Mellstrand T; Svedmyr N
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium absorption from ordinary and from sustained-release tablets.
    Otto U; Paalzow L; Surén G
    Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies of a sustained-release potassium salt preparation].
    Nukada T
    Nihon Rinsho; 1977 Dec; 35(12):4305-9. PubMed ID: 342763
    [No Abstract]   [Full Text] [Related]  

  • 20. Micro-K potassium supplement.
    Med Lett Drugs Ther; 1982 Aug; 24(615):71-2. PubMed ID: 7099109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.